N

North Dallas Research Associate | McKinney, TX

Research site
(Unclaimed)
Location
4201 Medical Center Drive, Suite 380, McKinney, Texas, United States of America
Site insights

Top conditions

Peripheral Arterial Disease (9 trials)

Heart Failure (8 trials)

Peripheral Vascular Diseases (7 trials)

Vascular Diseases (5 trials)

Atrial Fibrillation (3 trials)

Top treatments

Macitentan
Apixaban
Tovinontrine
Iron
Prasugrel
Dabigatran
PB1046
Finerenone
LY3298176
Tirzepatide

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

7 of 23
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)

The main purpose of this study is to assess the efficacy and safety of Tirzepatide (LY3298176) in participants with heart failure with preserved ejec...

Active, not recruiting
Heart Failure With Preserved Ejection Fraction
Obesity
Other: Placebo
Drug: Tirzepatide

The purpose of this study is to evaluate the safety and effectiveness of tovinontrine compared to placebo to lower NT-proBNP in patients with chronic...

Enrolling
Cardiovascular Diseases
Heart Failure With Reduced Ejection Fraction
Drug: Placebo
Drug: Tovinontrine (CRD-750)

The purpose of this study is to evaluate the safety and effectiveness of tovinontrine compared to placebo to lower NT-proBNP in patients with chronic...

Enrolling
Cardiovascular Diseases
Heart Failure Preserved Ejection Fraction
Drug: Placebo
Drug: Tovinontrine (CRD-750

To demonstrate the safety and efficacy of the SurVeil Drug-Coated Balloon (DCB) for treatment of subjects with symptomatic peripheral artery disease...

Active, not recruiting
Peripheral Vascular Disease
Femoropopliteal Artery Occlusion
Device: Surmodics SurVeil DCB
Device: Medtronic IN.PACT Admiral DCB

The purpose of this study is to evaluate the effect of finerenone compared to placebo (a tablet without active substance) in the reduction of cardiov...

Active, not recruiting
Heart Failure
Other: Placebo
Drug: Finerenone (BAY94-8862)

The primary objective of the TORUS 2 IDE Clinical Study is to evaluate the safety and effectiveness of the TORUS Stent Graft System in the treatment...

Active, not recruiting
Peripheral Arterial Disease
Device: TORUS Stent Graft System

This is a prospective, multi-center, single-arm, non-blinded clinical trial designed to investigate the safety and efficacy of the Vesper DUO Venous...

Active, not recruiting
Deep Vein Thrombosis
Chronic Venous Insufficiency
Device: Duo Venous Stent System

Trial sponsors

Actelion Pharmaceuticals logo

Actelion Pharmaceuticals (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems